Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Larsen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
La Revue Du Praticien|April 2, 2011
[Epidemiology of viral hepatitis in France]Denise Antona, Elisabeth Couturier, Christine Larsen
Psychiatric Services (Washington, D.C.)|March 16, 2018
Coteaching Recovery to Mental Health Care ProfessionalsChristine Larsen, Mads Lange, Kim Jørgensen, et al.
BMC Medical Research Methodology|June 12, 2012
Practical considerations for sensitivity analysis after multiple imputation applied to epidemiological studies with incomplete dataVanina Héraud-Bousquet, Christine Larsen, James Carpenter, et al.
Plos One|May 12, 2015
The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014Cécile Brouard, Yann Le Strat, Christine Larsen, et al.
AIDS (London, England)|August 26, 2006
Cost-effectiveness of HIV post-exposure prophylaxis in FranceMagid Herida, Christine Larsen, Florence Lot, et al.
Pharmaceutics|May 27, 2026
Dose Accuracy and Content Uniformity of Low-Dose Metoprolol Tablets: 3D Printing Compared with Tablet Splitting in Hospital Pharmacy SettingChristine Larsen, Farnaz Shokraneh, Julius Lahtinen, et al.
Journal of Medical Virology|September 10, 2010
Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in FranceChristine Larsen, Vanina Bousquet, Elisabeth Delarocque-Astagneau, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 12, 2017
Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014Alice Sanna, Yann Le Strat, Françoise Roudot-Thoraval, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 12, 2014
Application of canaloplasty in glaucoma gene therapy: where are we?Zeynep Aktas, Baohe Tian, Jared McDonald, et al.
JMIR Research Protocols|October 14, 2018
Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016)Nathalie Lydié, Leila Saboni, Arnaud Gautier, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
La Revue Du Praticien|April 2, 2011
[Epidemiology of viral hepatitis in France]Denise Antona, Elisabeth Couturier, Christine Larsen
Psychiatric Services (Washington, D.C.)|March 16, 2018
Coteaching Recovery to Mental Health Care ProfessionalsChristine Larsen, Mads Lange, Kim Jørgensen, et al.
BMC Medical Research Methodology|June 12, 2012
Practical considerations for sensitivity analysis after multiple imputation applied to epidemiological studies with incomplete dataVanina Héraud-Bousquet, Christine Larsen, James Carpenter, et al.
Plos One|May 12, 2015
The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014Cécile Brouard, Yann Le Strat, Christine Larsen, et al.
AIDS (London, England)|August 26, 2006
Cost-effectiveness of HIV post-exposure prophylaxis in FranceMagid Herida, Christine Larsen, Florence Lot, et al.
Pharmaceutics|May 27, 2026
Dose Accuracy and Content Uniformity of Low-Dose Metoprolol Tablets: 3D Printing Compared with Tablet Splitting in Hospital Pharmacy SettingChristine Larsen, Farnaz Shokraneh, Julius Lahtinen, et al.
Journal of Medical Virology|September 10, 2010
Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in FranceChristine Larsen, Vanina Bousquet, Elisabeth Delarocque-Astagneau, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 12, 2017
Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014Alice Sanna, Yann Le Strat, Françoise Roudot-Thoraval, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 12, 2014
Application of canaloplasty in glaucoma gene therapy: where are we?Zeynep Aktas, Baohe Tian, Jared McDonald, et al.
JMIR Research Protocols|October 14, 2018
Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016)Nathalie Lydié, Leila Saboni, Arnaud Gautier, et al.
Pageof 2